Prescribing Practices and Barriers of Biologics for Chronic Rhinosinusitis Amongst Otolaryngologists

Christopher M. Bell,Andrew V. Thamboo,Eric Monteiro,Jonathan Yip

DOI: https://doi.org/10.1002/lary.31370

IF: 2.97

2024-02-29

The Laryngoscope

Abstract:Rhinologists are more comfortable with prescribing and managing biologics for CRSwNP compared with non‐rhinologist colleagues. Clinicians prescribing biologic medications for CRSwNP should be familiar with guidelines, indications, and potential adverse events. Objective(s) Biologics for chronic rhinosinusitis with nasal polyposis (CRSwNP) are an evolving therapeutic option, but there are limited data on physician experiences in prescribing them. The goal of this study was to gain a better understanding of these experiences including prescribing practices, patient factors which guide prescriber decision, and physician and patient‐reported issues which might limit cost‐effectiveness of these therapies. Methods A survey was distributed to attending otolaryngologists using the Canadian Society of Otolaryngology (CSOHNS) email distribution and eSurvey program. Responses were tabulated for the entire cohort and compared between rhinologists and non‐rhinologists where appropriate. Frequencies and proportions were expressed as a percentage of total respondents. Fisher's exact test was used for statistical analysis between groups. Results Seventy‐nine total survey responses were recorded representing a response rate of 43%. Significantly more rhinologists reported prescribing biologic medications on their own (100% vs. 50%; p

medicine, research & experimental,otorhinolaryngology